» Articles » PMID: 38892035

The Relationship Between Circadian Rhythm and Cancer Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Jun 19
PMID 38892035
Authors
Affiliations
Soon will be listed here.
Abstract

The circadian clock regulates biological cycles across species and is crucial for physiological activities and biochemical reactions, including cancer onset and development. The interplay between the circadian rhythm and cancer involves regulating cell division, DNA repair, immune function, hormonal balance, and the potential for chronotherapy. This highlights the importance of maintaining a healthy circadian rhythm for cancer prevention and treatment. This article investigates the complex relationship between the circadian rhythm and cancer, exploring how disruptions to the internal clock may contribute to tumorigenesis and influence cancer progression. Numerous databases are utilized to conduct searches for articles, such as NCBI, MEDLINE, and Scopus. The keywords used throughout the academic archives are "circadian rhythm", "cancer", and "circadian clock". Maintaining a healthy circadian cycle involves prioritizing healthy sleep habits and minimizing disruptions, such as consistent sleep schedules, reduced artificial light exposure, and meal timing adjustments. Dysregulation of the circadian clock gene and cell cycle can cause tumor growth, leading to the need to regulate the circadian cycle for better treatment outcomes. The circadian clock components significantly impact cellular responses to DNA damage, influencing cancer development. Understanding the circadian rhythm's role in tumor diseases and their therapeutic targets is essential for treating and preventing cancer. Disruptions to the circadian rhythm can promote abnormal cell development and tumor metastasis, potentially due to immune system imbalances and hormonal fluctuations.

Citing Articles

The mediating role of the TyG index in the relationship between circadian syndrome and cancer among middle-aged and elderly Chinese.

Bai Z, Liang J, Nie Y, Wang S, Chang D BMC Cancer. 2025; 25(1):431.

PMID: 40065285 PMC: 11895363. DOI: 10.1186/s12885-025-13816-7.


The role of circadian rhythm regulator PERs in oxidative stress, immunity, and cancer development.

Zhao B, Nepovimova E, Wu Q Cell Commun Signal. 2025; 23(1):30.

PMID: 39825442 PMC: 11740368. DOI: 10.1186/s12964-025-02040-2.


Circadian Rhythm Disruption in Cancer Survivors: From Oncogenesis to Quality of Life.

Kisamore C, Kisamore C, Walker 2nd W Cancer Med. 2024; 13(20):e70353.

PMID: 39463009 PMC: 11513439. DOI: 10.1002/cam4.70353.


The Influence of Circadian Rhythms on DNA Damage Repair in Skin Photoaging.

Su Z, Hu Q, Li X, Wang Z, Xie Y Int J Mol Sci. 2024; 25(20).

PMID: 39456709 PMC: 11507642. DOI: 10.3390/ijms252010926.


The immunomodulatory effects of vitamins in cancer.

Munteanu C, Marza S, Papuc I Front Immunol. 2024; 15:1464329.

PMID: 39434876 PMC: 11491384. DOI: 10.3389/fimmu.2024.1464329.

References
1.
Cadenas C, van de Sandt L, Edlund K, Lohr M, Hellwig B, Marchan R . Loss of circadian clock gene expression is associated with tumor progression in breast cancer. Cell Cycle. 2014; 13(20):3282-91. PMC: 4613905. DOI: 10.4161/15384101.2014.954454. View

2.
Semenza G . HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med. 2002; 8(4 Suppl):S62-7. DOI: 10.1016/s1471-4914(02)02317-1. View

3.
Anafi R, Lee Y, Sato T, Venkataraman A, Ramanathan C, Kavakli I . Machine learning helps identify CHRONO as a circadian clock component. PLoS Biol. 2014; 12(4):e1001840. PMC: 3988006. DOI: 10.1371/journal.pbio.1001840. View

4.
Farshadi E, van der Horst G, Chaves I . Molecular Links between the Circadian Clock and the Cell Cycle. J Mol Biol. 2020; 432(12):3515-3524. DOI: 10.1016/j.jmb.2020.04.003. View

5.
Malhotra S, Sawhney G, Pandhi P . The therapeutic potential of melatonin: a review of the science. MedGenMed. 2004; 6(2):46. PMC: 1395802. View